BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health an… Read more
BioHarvest Sciences Inc. Common Stock (BHST) - Total Liabilities
Latest total liabilities as of September 2025: $27.45 Million USD
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has total liabilities worth $27.45 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BioHarvest Sciences Inc. Common Stock - Total Liabilities Trend (2020–2024)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BioHarvest Sciences Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taylor Calvin B Bksh
OTCQX:TYCB
|
USA | $886.83 Million |
|
Xplora Technologies As
OL:XPLRA
|
Norway | Nkr1.64 Billion |
|
Arsan Tekstil Ticaret ve Sanayi AS
IS:ARSAN
|
Turkey | TL1.31 Billion |
|
Financiere Moncey S.A.
PA:FMONC
|
France | €403.00K |
|
Happy Belly Food Group Inc.
OTCQB:HBFGF
|
USA | $12.15 Million |
|
Dohome Public Company Limited
BK:DOHOME
|
Thailand | ฿20.51 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down BioHarvest Sciences Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioHarvest Sciences Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioHarvest Sciences Inc. Common Stock (2020–2024)
The table below shows the annual total liabilities of BioHarvest Sciences Inc. Common Stock from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $23.67 Million | -20.71% |
| 2023-12-31 | $29.86 Million | +94.85% |
| 2022-12-31 | $15.32 Million | +108.38% |
| 2021-12-31 | $7.35 Million | -3.24% |
| 2020-12-31 | $7.60 Million | -- |